Role of Factor XII in hemostasis and thrombosis: clinical implications (Q34644690)

3 August 2017

1 reference

title

Role of Factor XII in hemostasis and thrombosis: clinical implications (English)

1 reference

3 August 2017

0 references

Thomas Renné

1

1 reference

3 August 2017

David Gailani

series ordinal

2

1 reference

3 August 2017

publication date

1 July 2007

1 reference

Expert Review of Cardiovascular Therapy

3 August 2017

published in

1 reference

3 August 2017

volume

5

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

733-741

1 reference

Mortality by cause for eight regions of the world: Global Burden of Disease Study

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Molecular and cellular biology of blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Platelets in atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Thrombus formation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Platelet coagulation-protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Platelets promote coagulation factor XII-mediated proteolytic cascade systems in plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Hemorrhagic complications of anticoagulant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Are hemostasis and thrombosis two sides of the same coin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

AN ENZYME CASCADE IN THE BLOOD CLOTTING MECHANISM, AND ITS FUNCTION AS A BIOCHEMICAL AMPLIFIER.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

The molecular basis of blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Mice lacking factor VII develop normally but suffer fatal perinatal bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Role of tissue factor in hemostasis, thrombosis, and vascular development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Tissue factor: a key molecule in hemostatic and nonhemostatic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

High molecular weight kininogen utilizes heparan sulfate proteoglycans for accumulation on endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Bradykinin-mediated angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Hereditary angioedema with normal C1-inhibitor activity in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Activation of the classical pathway of complement by Hageman factor fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

The intrinsic pathway of coagulation: a target for treating thromboembolic disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Positive feedbacks of coagulation: their role in threshold regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

The blood coagulation system as a molecular machine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Acidocalcisomes - conserved from bacteria to man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Polyphosphate modulates blood coagulation and fibrinolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Activation of the contact-phase system on bacterial surfaces--a clue to serious complications in infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Factor XII deficiency: a thrombophilic risk factor for retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

The occasional venous thromboses seen in patients with severe (homozygous) FXII deficiency are probably due to associated risk factors: a study of prevalence in 21 patients and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

John Hageman's factor and deep-vein thrombosis: Leiden thrombophilia Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

The dynamics of thrombin formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors XI and XII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Thrombin activatable fibrinolysis inhibitor (TAFI)--how does thrombin regulate fibrinolysis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Alterations of coagulation and fibrinolytic and kallikrein-kinin systems in the acute and postacute phases in patients with unstable angina pectoris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Activated factor XII levels and factor XII 46C>T genotype in relation to coronary artery calcification in patients with type 1 diabetes and healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

In vivo bypass of hemophilia A coagulation defect by factor XIIa implant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Factor XI activation in a revised model of blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Defective thrombus formation in mice lacking coagulation factor XII

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Effects of factor IX or factor XI deficiency on ferric chloride-induced carotid artery occlusion in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Contact factors in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

Factor XII activity and antigen concentrations in patients suffering from recurrent thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.4.733

21 January 2018

Identifiers

DOI

10.1586/14779072.5.4.733

1 reference

3 August 2017

1 reference